Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| [[17-(Diphosphonomethyl)-26,28-dihydroxy-25,27-dipropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3,5,7(28),9(27),10,12,15(26),16,18,21,23-dodecaenyl]-phosphonomethyl]phosphonic acid | IC50 | 32000.0 [1] | |
| 2-(Oxalyl-amino)-benzoic acid | Ki | 33000.0 [1] | |
| 2-(Oxalyl-amino)-4,5,6,7-tetrahydro-thieno[2,3-C]pyridine-3-carboxylic acid | Ki | 560000.0 [1] | |
| (1-Amino-2-phenylethyl)phosphonic acid | IC50 | 139000.0 [1] | |
| Razuprotafib | IC50 | 0.0 [1] | |
MLA | "Quest Database™ Receptor-type tyrosine-protein phosphatase beta Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 21 Jan. 2026, https://www.aatbio.com/data-sets/receptor-type-tyrosine-protein-phosphatase-beta-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2026, January 21). Quest Database™ Receptor-type tyrosine-protein phosphatase beta Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/receptor-type-tyrosine-protein-phosphatase-beta-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |